165 related articles for article (PubMed ID: 10630964)
1. The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts.
Cinatl J; Kotchetkov R; Weimer E; Blaheta RA; Scholz M; Vogel JU; Gümbel HO; Doerr HW
J Med Virol; 2000 Mar; 60(3):313-23. PubMed ID: 10630964
[TBL] [Abstract][Full Text] [Related]
2. Antiviral and immunomodulatory activity of the metal chelator ethylenediaminedisuccinic acid against cytomegalovirus in vitro and in vivo.
Vogel JU; Michaelis M; Neyts J; Blaheta RA; Snoeck R; Andrei G; De Clercq E; Rabenau HF; Kreuter J; Cinatl J; Doerr HW
Antiviral Res; 2002 Jul; 55(1):179-88. PubMed ID: 12076762
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory potential of cytomegalovirus infection. specific inhibition of cytomegalovirus immediate-early expression in combination with antioxidants as a novel treatment strategy?
Cinatl J; Vogel JU; Kotchetkov R; Scholz M; Doerr HW
Intervirology; 1999; 42(5-6):419-24. PubMed ID: 10702726
[TBL] [Abstract][Full Text] [Related]
4. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
van der Strate BW; De Boer FM; Bakker HI; Meijer DK; Molema G; Harmsen MC
Antiviral Res; 2003 Apr; 58(2):159-65. PubMed ID: 12742576
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotide ISIS 2922 targets IE-expression and prevents HCMV-IE-induced suppression of TSP-1 and TSP-2 expression.
Margraf S; Bittoova M; Vogel JU; Kotchekov R; Doerr HW; Cinatl J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1425-8. PubMed ID: 11563036
[TBL] [Abstract][Full Text] [Related]
6. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
Neyts J; Snoeck R; Balzarini J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
[TBL] [Abstract][Full Text] [Related]
7. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
Snoeck R; Andrei G; De Clercq E
Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
[TBL] [Abstract][Full Text] [Related]
8. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Takahashi K
Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
[TBL] [Abstract][Full Text] [Related]
10. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
11. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs.
Azad RF; Brown-Driver V; Buckheit RW; Anderson KP
Antiviral Res; 1995 Oct; 28(2):101-11. PubMed ID: 8585764
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment.
Craigen JL; Grundy JE
Transplantation; 1996 Oct; 62(8):1102-8. PubMed ID: 8900310
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
Maggs DJ; Clarke HE
Am J Vet Res; 2004 Apr; 65(4):399-403. PubMed ID: 15077679
[TBL] [Abstract][Full Text] [Related]
15. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
Cihlar T; Fuller MD; Cherrington JM
J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of ganciclovir and cidofovir in cells infected with drug-resistant and wild-type strains of murine cytomegalovirus.
Okleberry KM; Warren RP; Smee DF
Antiviral Res; 1997 Jul; 35(2):83-90. PubMed ID: 9217245
[TBL] [Abstract][Full Text] [Related]
18. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.
Kern ER; Rybak RJ; Hartline CB; Bidanset DJ
Antivir Chem Chemother; 2001; 12 Suppl 1():149-56. PubMed ID: 11594682
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53.
Cinatl J; Kotchetkov R; Scholz M; Cinatl J; Vogel JU; Driever PH; Doerr HW
Am J Pathol; 1999 Jul; 155(1):285-92. PubMed ID: 10393860
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.
Stals FS; de Clercq E; Bruggeman CA
Antimicrob Agents Chemother; 1991 Nov; 35(11):2262-6. PubMed ID: 1666493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
